高效合成氯代苯醌基碳糖苷

报道一种简便、高效的氯代苯醌碳糖苷3a (3b)的合成新方法: 以苯醌基碳苷1a (1b)为原料, 经CH3COCl/THF/H2O体系进行加成反应, 高区域选择性获得糖基间位氯代的氢醌基碳苷2a (2b), 继而通过硝酸铈铵(CAN)氧化得到目标结构3a (3b), 并对所合成的化合物进行了结构表征.     

新型碳苷糖类维生素D_2衍生物的合成

以D-葡萄糖为原料,经碳苷化反应,酰化反应和脯氨酸-DIPEA催化的aldol反应制得2个碳苷糖[1-(4'-羟基苯基)-4-C-β-四乙酰基葡萄糖基-3-烯-2-酮(5a)和1-(3-羟基苯基)-4-C-β-四乙酰基葡萄糖基-3-烯-2-酮(5b)];5与琥珀酸维生素D2经Steglich酯化反应合成了2个新型碳苷糖类维生素D2衍生物,其结构经1H NMR,13C NMR和HR-ESI-MS表征。     

氯代苄基葡萄糖在芳香碳苷立体选择性合成中的应用

Hosomi等人曾报道了1-α-氯代-2,3,4,6-四-O-苄基-D-吡喃葡萄糖(1)与烯丙基硅醚反应主要得到α异构体占优势的烯丙基碳苷。我们研究了化合物1在Lewis酸存在下和芳香醚反应,结果发现,产物都是β构型的芳香碳苷。这与Schmidt等人和Williams等     

异黄酮碳苷类化合物(葛根素)的全合成

采用查尔酮途径全合成了一种异黄酮碳苷类化合物（葛根素）,总收率1.0%。首先4-乙基-6-叔丁基间苯二酚与2,3,4,6-四-O-苄基吡喃葡萄糖基三氟乙酰亚胺酯发生糖基化反应制得碳苷(3); 3依次经脱叔丁基和氧化制得苯乙酮类化合物(5); 5经查尔酮路线转化为葛根素,其结构经¹H NMR, ¹³C NMR和HR-MS(ESI)确证。     

含烷氧基取代的三唑类结构的尿酸转运体1抑制剂的高效合成方法

含烷氧基取代的三唑类结构的尿酸转运体1(URAT1)抑制剂3-(4-(4-环丙基萘-1-基)-5-甲氧基-4H-1,2,4-三唑-3-基)丙酸(1a)和3-[4-(4-环丙基萘-1-基)-5-乙氧基-4H-1,2,4-三唑-3-基]丙酸(1b)是一类重要的药物先导化合物,但是其现有合成路线收率非常低(1a和1b的总收率分别为3.3%和3.0%),为了对其进行进一步的构效关系研究,需要收率高的路线.经过详细研究发现了两条高效的合成路线(A和B),分别以CuCl催化的醇钠对溴代三唑进行芳香族亲核取代反应和醇钠直接对甲磺酰基取代的三唑进行芳香族亲核取代反应作为关键反应,并对重要步骤的反应条件进行深入优化.这两条路线具有收率高的优点,除了可以作为先导化合物1a和1b继续进行构效关系研究的合成路线外,还可以为含烷氧基取代的其他杂环化合物的合成提供有价值的借鉴.     

4-(3-氯苯乙基)呱啶的简便合成

以廉价易得的N-Boc呱啶-4-甲醇（1）和间氯苄氯（3）为原料,经Swern 氧化、Wittig反应、钯碳催化加氢和脱保护基反应合成目标化合物4-(3-氯苯乙基)呱啶盐酸盐(7)。路线总收率达到56%,化学纯度96.6%。加氢不脱氯反应的最佳反应条件为：以含量为10%干钯碳催化加氢,二氧六环为溶剂,反应时间3h。化合物7的结构及纯度经¹H NMR,¹³C NMR和MS（EI）确证。该合成方法具有反应条件温和、操作简单、收率高等优点。      

4-氧代-3（4H）-喹唑啉-5-羧酸的合成

以2-氨基-6-甲基苯甲酸为起始原料,通过合环反应生成两种4-氧代-3(4H)-喹唑啉-5-羧酸衍生物(1a, 1b), 1a, 1b分别经高锰酸钾氧化合成了4-氧代-3(4H)-喹唑啉-5-羧酸（2a, 2b）,其结构经¹H NMR, ¹³C NMR和MS表征。研究了投料比｛r［n(高锰酸钾) :n(5-甲基-3(4H)-喹唑啉-4-酮)］｝和反应温度等对收率的影响。结果表明：在最佳反应条件（r=7:1,中性高锰酸钾氧化,于90 ℃反应）下合成2总收率可达66%。     

呋喃碳苷衍生物的合成及主产物构型的确认

在三氯氧磷催化下将2-甲基-5-(2′-氯-2′-脱氧-D-半乳糖-1-丁醇基)-3-乙酰基呋喃经脱水反应得到呋喃碳苷衍生物(2-甲基-5-[(4′-α-羟基-3′-β-氯)-2′-四氢呋喃基]-3-乙酰基呋喃),并对反应机理进行了讨论.通过2D NMR图谱确认了主产物的构型为α构型.     

2,6-二甲基-3,5-二氯-4-吡啶酚糖苷的合成

在相转移催化条件下, 使 a-D-乙酰基化溴代的葡萄糖、半乳糖、葡萄糖醛酸甲酯1a, 1b, 1c分别与2,6-二甲基-3,5-二氯-4-吡啶酚(俗称氯吡醇, 氯羟吡啶)作用, 合成了氯吡醇的糖苷: 1-O-(2',6'-二甲基-3',5'-二氯-4'-吡啶基)-2,3,4,6-四-O-乙酰基-β-D-葡萄吡喃糖苷(2a), 1-O-(2',6'-二甲基-3',5'-二氯-4'-吡啶基)-2,3,4,6-四-O-乙酰基β-D-半乳吡喃糖苷(2b), 1-O-(2'6'-二甲基-3',5'-二氯-4'-吡啶基)-2,3,4-三-O-乙酰基-β-D-葡萄吡喃糖醛酸甲酯(2c)。2a, 2b, 2c分别在甲醇中氨解, 相应得到: 1-O-(2', 6'-二甲基-3',5'-二氯-4'-吡啶基)-β-D-葡萄吡喃糖苷(3a), 1-O(2',6'-二甲基-3',5'-二氯-4'-吡啶基)-β-D-半乳吡喃糖苷(3b),1-O-(2', 6'-二甲基-3',5'-二氯-(4'-吡啶基)-β-D-葡萄吡喃糖醛酸酰胺(3c)。2c用CH~3ONa/CH~3OH处理, 得到1-O-(2',6'-二甲基-3',5'-二氯-4'-吡啶基)-β-D-葡萄吡喃糖醛酸甲酯(3d)。     

无溶剂、无催化剂条件下α-腺嘌呤阿拉伯糖苷的合成

为了发展有效合成α-腺嘌呤阿拉伯糖苷的方法,以1,2,3,5-四-O-乙酰基-β-D-阿拉伯糖和6-氯嘌呤为原料,在微波辐射和无溶剂、无催化剂条件下反应得到中间体9-α-D-(2',3',5'-三-O-乙酰基)阿拉伯呋喃糖基-6-氯嘌呤,收率85%。 该中间体物在Na₂CO₃催化下脱除乙酰基,然后“一锅”加入饱和的NH₃/CH₃OH溶液氨解,以90%的收率得到α-腺嘌呤阿拉伯糖苷。 关键中间体9-α-D-(2',3',5'-三-O-乙酰基)阿拉伯呋喃糖基-6-氯嘌呤的合成反应规模可以扩大到100 g。 类似地合成α-2-氟腺嘌呤阿拉伯糖苷和α-2-氨基腺嘌呤阿拉伯糖苷。     

Synthesis of pyrazole derivatives as potential bioisosteres of thromboxane-synthetase inhibitors

A series of ω-carboalkenyl pyrazole derivatives have been synthesized as potential thromboxane-synthetase inhibitors considering the close bioisosteric relationship between the pyrazole ring and other heteroaromatic carboalkenyl compounds exhibiting inhibitory activity. (E)-7-(1-Phenylpyrazol-4-yl)hept-2-enoic acid (4b) were prepared in 28% overall yield from its minor bis-homologue, (E)-5-(1-phenylpyrazol-4-yl)pent-2-enoic acid (4a) , obtained from 4-formyl-1-phenylpyrazole (6) in 17% overall yield. Compounds 4a, 4b, 7, 8 and 13 were screened for their ability to inhibit the in vitro rabbit blood platelet aggregation induced by collagen using the Born test. Among the active compounds 4a exhibited an important inhibition at 1 μM concentration.     

Effect of Extraction Solvent and Temperature on Polyphenol Profiles,Antioxidant and Anti-Inflammatory Effects of Red Grape Skin By-Product

A fully-detailed LC-MS qualitative profiling of red grape skin, extracted with a mixture of ethanol and water (70:30 v:v) has permitted the identification of 65 compounds which can be classified into the following chemical classes: organic and phenolic acids (14 compounds), stilbenoids (1 compound), flavanols (21 compounds), flavonols (15 compounds) and anthocyanins (14 compounds). The extraction yield obtained with water at different temperatures (100 °C, 70 °C, room temperature) was then evaluated and the overall polyphenol content indicates that EtOH:H₂O solvent is the most efficient and selective for polyphenol extraction. However, by analyzing the recovery yield of each single polyphenol, we found that water extraction under heating conditions is effective (extraction yield similar or even better in respect to the binary solvent) for some polyphenolic classes, such as hydrophilic procyanidins, phenolic acids, flavonol glucosides and stilbenoids. However, according to their lipophilic character, a poor yield was found for the most lipophilic components, such as flavonol aglycones, and in general for anthocyanins. The radical scavenging activity was in accordance with the polyphenol content, and hence, much higher for the extract obtained with the binary solvent in respect to water extraction. All the tested extracts were found to have an anti-inflammatory activity in the R3/1 cell line with NF-kb reporter challenged with 0.01 µg/mL of IL-1α, in a 1 to 250 µg/mL concentration range. An intriguing result was that the EtOH:H₂O extract was found to be superimposable with that obtained using water at 100 °C despite the lower polyphenol content. Taken together, the results show the bioactive potentialities of grape skin extracts and the possibility to exploit this rich industrial waste. Water extraction carried out by heating is an easy, low-cost and environmentally friendly extraction method for some polyphenol classes and may have great potential for extracts with anti-inflammatory activities.     

The synthesis of carboacycles derived from B,B'-bis(aryl) derivatives of icosahedral ortho-carborane

Reactions of both closo-9,12-I2-1,2-C2B10H10 and closo-9,10-I2-1,7-C2B10H10 with an excess of aryl magnesium bromide in the presence of [PdCl2(PPh3)2] afford the corresponding closo-9,12-(4-R-C6H4)2-1,2-C2B10H10 [R=H (1), Me (2), OMe (3), SMe (4), N(CH3)2 (5), Cl (6)] and closo-9,10-(4-R-C6H4)2-1,7-C2B10H10 [R'=Me (7), OMe (8), N(CH3)2 (9), Cl (10), and -C[(OCH2)2]CH3 (11)] compounds in high yields. The anisole derivatives 3 and 8 were deprotected to yield the corresponding bis-phenols 12 and 13, respectively. Structural analyses of compounds 1, 3, 6, and 12 are reported. Re-etherification of compound 12 by using gamma-bromotriethyleneglycol methyl ether provided 14 (R=(CH2CH2O)3CH3). Oxidation of 4 with ceric(IV) ammonium nitrate (CAN) generated the bis-sulfoxide 15 (R=S(O)Me). Deprotection of compound 11 led to the corresponding acetyl derivative 18 (R'=C(O)Me). Bis-anisole 3 was tethered with 1,3-dibromopropane, 1,6-dibromohexane, 1,8-dibromooctane, 4,4'-bis(iodomethyl)-1,1'-biphenyl, and alpha,alpha'-dibromo-2,6-lutidine to afford the dimers 20b, 21b, 22b, 23b, and 24b, respectively. The tetrameric carboracycles 27a and 30a, as well as the dimeric 29c were obtained through repetitive coupling of the dimeric compounds 20b, 24b, and 22b with 1,3-dibromopropane, alpha,alpha'-dibromo-2,6-lutidine, and 1,8-dibromooctane, respectively. The tetrameric carboracycle 28a was obtained upon consecutive reactions of 1 with 1,4-dibromobutane. Hexameric carboracycle 28b was identified as a byproduct. Exhaustive ether cleavage of 27a generated octaphenol 31a. Re-etherification of 31a with trimethylenesultone provided the octasulfonate 32a, the first example of a water-soluble carboracycle. Linkage of dimer 23b with alpha,alpha'-dibromolutidine yielded the cyclic tetrameric tetrapyridyl derivative 30a in low yield. The structures of the carboracycles 27a, 28a, 28b, and 30a have been confirmed by Xray crystallography. In addition, the compounds 28a,b are the first reported carboracycles that interact with solvent molecules in a host-guest fashion.     

New convergent synthesis of 1alpha,25-dihydroxyvitamin D3 and its analogues by Suzuki-Miyaura coupling between A-ring and C,D-ring parts

A new convergent method for the synthesis of 1alpha,25-dihydroxyvitamin D(3) and its analogues has been developed that involves efficient preparation of the A-ring part 1a, (Z)-(3S,5R)-1-bromomethylene-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexane, starting from epichlorohydrin (4) and its Suzuki-Miyaura coupling reaction with the C,D-ring part 12. Thus, (R)-4 was converted to (3S,5R)-5-(tert-butyldimethylsilyloxy)-8-(trimethylsilyl)-oct-1-en-7-yn-3-ol (3a) through a ten-step reaction sequence in 49% overall yield. Compound 3a thus obtained was treated with a Ti(O-i-Pr)(4)/2 i-PrMgCl reagent and then with NBS to afford (Z)-(1S,2S,5R)-2-bromomethyl-3-[bromo(trimethylsilyl)methylene]-5-(tert-butyldimethylsilyloxy)cyclohexanol (10a) in 51% yield, from which 1a was obtained in 87% yield by sequential treatment with TBSCl/imidazole, DBU, and Cs(2)CO(3). The resulting A-ring intermediate 1a was reacted with alkenylboronate 12 in the presence of a PdCl(2)(dppf) catalyst to furnish 1alpha,25-dihydroxyvitamin D(3) in 82% yield after protodesilylation. Similarly, all of the other three possible stereoisomers of A-ring parts 1b, 1c, and 1d were prepared, from which 1-epi-, 3-epi-, and 1,3-di-epi-1alpha,25-dihydroxyvitamin D(3) were synthesized by coupling with 12 in excellent yield, respectively. Starting from 1a and 1c, des-C,D-1alpha,25-dihydroxyvitamin D(3) analogues, retiferol 13 and its 3-epi derivative, were also prepared, respectively.     

Synthesis and antidiabetic activity of novel triazole derivatives containing amino acids

New series of triazole derivatives coupled with amino acids 1a-h were obtained via multicomponent reaction of 2-hydroxy benzaldehyde or 2-hydroxy acetophenone with thiosemicarbazide and different amino acids. The obtained compounds were reacted with p-toluinesulfonyl chloride 2 to give the corresponding sulfonamides 3a-h . Compound 1b was allowed to react with different aromatic aldehydes or cyclic ketone under alkaline conditions to afford the expected imino compounds 4a-d and 6a-c , respectively. These compounds were allowed to react with ethyl glycolate to yield the expected thiazolidinone derivatives 5a-d or 7a-c , respectively. Structures of the newly synthesized compounds were found to be in accordance with their elemental analyses and spectral data. The obtained compounds exhibited very prominent in vitro and in vivo antihyperglycemic effect at a dose of 40 mg/kg body weight compared to the standard drug gliclazide and control. The antidiabetic effect was investigated using oral glucose tolerance test in normal and non-insulin-dependent diabetes mellitus (NIDDM) in STZ-rat model. Compounds 3a - h , 5b , 5c , 5d , 7a , 7b , and 7c showed significant activity in lowering blood glucose (more than 80%) compared to the NIDDM control.     

2H-1,2,4-benzothiadiazine 1,1-dioxides 2. A condensation of 2-aminobenzenesulfonamide with chloroalkyl isothiocyanates

A reaction of 2-aminobenzenesulfonamide ( 1 ) with 2-chloroethyl or 3-chloropropyl isothiocyanate in isopropanol afforded 2-(2′-chloroethylthioureido)- and 2-(3′-chloropropylthioureido)benzenesulfonamides ( 2a,b ) in 67% and 55% yield respectively. Treatment of 2a,b with triethylamine in methanol at room temperature furnished 3-(2′-aminoethylthio)- and 3-(3′-aminopropylthio)-2H-1,2,4-benzothiadiazine 1,1-dioxides ( 9a,b ) in quantitative yield. Heating 2b to reflux in methanol under neutral conditions gave 9b but in the form of the hydrochloride 8b which could be converted into the free base 9b by treating with ammonia water. When compounds 2a,b were treated with triethylamine in methanol at elevated temperature, 3-(2′-mercaptoethylamino)- and 3-(3′-mercaptopropylamino)-2H-1,2,4-benzothiadiazine 1,1-dioxides ( 10a,b ) were obtained in good yield. Alternatively, 10a,b could also be prepared from 9a,b in 95% and 77% yield respectively.     

The alkaline hydrolysis of flavonoid glycosides

Conclusions 1. The alkaline hydrolysis of flavonoid glycosides has been studied.2. In an alkaline medium 3-glycosides, C-glycosides, and biosides having 1, 2 bonds between the sugars are stable.3. The difference in the stabilities of the glycosides to alkalis can be used in studying flavonoid O-diglycosides, O-biosides with different positions of the bond, O,C-diglycosides, and O,C-biosides.Khimiya Prirodnykh Soedinenii, Vol. 5, No. 5, pp. 366–369, 1969     

8-5’新木脂素类化合物的合成方法研究

对羟基桂皮酸甲酯和阿魏酸甲酯分别在氧化银催化下发生自由基仿生氧化偶联反应, 合成得苯并二氢呋喃环结构化合物1, 1经甲基化反应得2. 1a和1和2分别在无水碳酸钾、10%氢氧化钠水溶液等不同的碱性条件下进行反应, 获得了11个苯并二氢呋喃环开环产物, 即8-5’新木脂素类化合物3a～9b, 实现了由苯并二氢呋喃新木脂素向8-5’新木脂素的转变, 也为合成芪类化合物提供了一种新方法. C-8位上的吸电子基团如酯基的影响使苯并二氢呋喃环易在碱性条件下开环形成8-5’新木脂素类化合物．所合成化合物的结构由MS, IR, 1H NMR和13C NMR进行了表征.     

Synthesis of mono- and 1,3-diaminocalix[4]arenes via Ullmann-type amination and amidation of 1,3-bistriflate esters of calix[4]arenes

Practical methods are described for the preparation of monoamines 4 and 1,3-diamines 5, bearing one or two amino group(s) instead of the hydroxy group(s) at the 28-position or at both the 26- and 28-positions of p-tert-butylcalix[4]arene (1a) and p-tert-butylthiacalix[4]arene (1b), via the Ullmann-type amination or amidation. Thus, the copper-catalyzed or mediated amination of the 1,3-bistriflate ester (2a) of 1a with benzylamine affords either mono(benzylamino) triflate 7a or 1,3-bis(benzylamine) 8 in a high yield, depending on the reaction conditions. On the other hand, the 1,3-bistriflate ester (2b) of 1b resists disubstitution and produces, under stoichiometric conditions, mono(benzylamino) triflate 7b. The disubstitution of 2b is achieved by amidation with tosylamide, giving 1,3-bis(tosylamide) 17b. The hydrogenolysis of the benzylamino moiety of 7a, followed by the hydrolysis of the Tf moiety, affords monoamine 4a, while the hydrogenolysis of 8 affords 1,3-diamine 5a. The amino moiety of 7b can be deprotected under acidic conditions to give, after hydrolysis, monoamine 4b. The hydrolysis of 17b affords 1,3-diamine 5b. The overall yields of compounds 4a, 4b, 5a, and 5b are 72%, 45%, 78%, and 24%, respectively, based on commercially available compounds 1 and are much higher than the ones previously reported in the literature.     

天然5,7-二羟基-3-异戊烯基黄酮与5-羟基-3-异戊烯基黄酮的全合成

以2,4,6-三羟基苯乙酮和2,6-二羟基苯乙酮为原料, 分别通过甲基保护酚羟基、 苯甲酰氯酰化、 Bake-Venkataraman重排、 异戊烯基化、 酸催化关环及EtSLi脱去甲基等6步反应, 以高收率完成了天然5,7-二羟基-3-异戊烯基黄酮(1a, 收率80.6%)和5-羟基-3-异戊烯基黄酮(1b, 收率84.9%)的全合成, 所有化合物均经 ¹H NMR 和 ¹³C NMR表征确定. 通过密度泛函理论方法对目标产物(1a和1b)的生物活性进行了预测. 结果表明, 3位异戊烯基侧链的存在能大大增强化合物相应的生物活性, 而且是化合物生物活性增强必需的取代基. 另外, 目标产物1a的生物活性高于产物1b, 归因于黄酮类化合物分子中A环上的7-OH属增效基团, 起到增强生物活性的作用, 化合物1a分子中A环上有7-OH, 而化合物1b分子中则无该基团. 本合成方法对其它3-烃基黄酮类天然化合物的合成具有潜在的适用性, 所预测的生物活性结果为3-烃基黄酮类化合物的构效关系研究奠定了基础.